Commonwealth Equity Services
DMAC icon

Commonwealth Equity Services’s DiaMedica Therapeutics DMAC Stock Holding History

Commonwealth Equity Services’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,277
Closed -$27K – 2904
2019
Q3 		$27K Buy
+13,277
New +$42.9K ﹤0.01% 2783

Other funds holding DMAC

MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

Commonwealth Equity Services's DMAC Position: Q4 2019 in Review

Commonwealth Equity Services sold out of DiaMedica Therapeutics (DMAC) in Q4 2019, closing a stake of 13,277 shares — an estimated $27K sold.

Commonwealth Equity Services first reported a position in DMAC in Q3 2019 and held it in 1 quarter. The position peaked at $27K in Q3 2019. 15 funds tracked by Wall St. Rank hold DMAC as of Q4 2019.

  • Commonwealth Equity Services reported no remaining DiaMedica Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Commonwealth Equity Services sold 13,277 DiaMedica Therapeutics shares in Q4 2019, an estimated $27K.
  • Commonwealth Equity Services first reported a position in DiaMedica Therapeutics in Q3 2019 and held it in 1 quarter.
  • Commonwealth Equity Services's DiaMedica Therapeutics position peaked at $27K in Q3 2019.
  • 15 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q4 2019.

Based on Commonwealth Equity Services's 13F filing for Q4 2019, filed 5 Feb 2020.